Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 7, 2005; 11(1): 122-126
Published online Jan 7, 2005. doi: 10.3748/wjg.v11.i1.122
Published online Jan 7, 2005. doi: 10.3748/wjg.v11.i1.122
Control n = 8 | Model n = 10 | OM n = 10 | IFN n = 9 | BR n = 10 | |
ALT | 48.00±3.0 | 51.33±6.5 | 67.70±3.31 | 41.33±1.8 | 53.80±5.2 |
PCIII | 5.83±0.4 | 9.91±3.1 | 7.46±0.71,2 | 6.68±0.31 | 6.56±0.41 |
CIV | 0.93±0.71 | 4.13±1.4 | 0.97±0.91 | 0.90±0.61 | 0.40±0.41 |
Group | n | 0 | I | II | III | IV |
Control | 8 | 8 | 0 | 0 | 0 | 0 |
Model | 10 | 0 | 5 | 1 | 1 | 3 |
OM | 10 | 2 | 7 | 0 | 1 | 0 |
IFN | 9 | 2 | 6 | 1 | 0 | 0 |
BR | 10 | 4 | 5 | 0 | 1 | 0 |
-
Citation: Wu CS, Piao XX, Piao DM, Jin YR, Li CH. Treatment of pig serum-induced rat liver fibrosis with
Boschniakia rossica , oxymatrine and interferon-α. World J Gastroenterol 2005; 11(1): 122-126 - URL: https://www.wjgnet.com/1007-9327/full/v11/i1/122.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i1.122